- Pages
- 12
- Published in
- United States of America
Premium
Rna Interference Therapeutic Zilebesiran:
2024
Tables
<Macro 'access_denied_modal'>
<Macro 'unauthorized_modal'>
Add to list
Citation
Alnylam Pharmaceuticals (United States), 2024. Rna Interference Therapeutic Zilebesiran:, Alnylam Pharmaceuticals (United States).
United States of America.
Retrieved from https://coilink.org/20.500.12592/bi91fqd on 15 Nov 2024. COI: 20.500.12592/bi91fqd.
Full-page Screenshot
